Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Significance Statement: Identifying biomarkers for predicting kidney transplant failure requires better understanding of the immune response to chronic allogeneic stimulation. The authors demonstrated that 1 year after kidney transplantation, the composition of CD8+memory T cell subsets in blood—specifically the ratio of terminally differentiated effector memory (TEMRA) and effector memory CD8+T cells—is associated with risk for subsequent graft failure and adds predictive value to a previously reported eight-variable clinical risk score. They also found that TEMRA CD8+T cells display a novel T cell receptor–independent mechanism of activation that is mediated through CD16 engagement and results in inflammation and antibody-dependent cellular cytotoxicity. These findings suggest a pivotal role for TEMRA CD8+T cells in chronic humoral and cellular rejection leading to kidney transplant failure. Future clinical benefits may include the use of CD8+memory T cell monitoring to improve risk prediction for graft failure and development of therapeutic strategies targeting TEMRA CD8+T cells. Background: Identifying biomarkers to predict kidney transplant failure and to define new therapeutic targets requires more comprehensive understanding of the immune response to chronic allogeneic stimulation. Methods: We investigated the frequency and function of CD8+T cell subsets—including effector memory (EM) and terminally differentiated EM (TEMRA) CD8+T cells—in blood samples from 284 kidney transplant recipients recruited 1 year post-transplant and followed for a median of 8.3 years. We also analyzed CD8+T cell reactivity to donor-specific PBMCs in 24 patients who had received living-donor kidney transplants. Results: Increased frequency of circulating TEMRA CD8+T cells at 1 year post-transplant associated with increased risk of graft failure during follow-up. This association remained after adjustment for a previously reported composite of eight clinical variables, the Kidney Transplant Failure Score. In contrast, increased frequency of EM CD8+T cells associated with reduced risk of graft failure. A distinct TEMRA CD8+T cell subpopulation was identified that was characterized by expression of Fc γ RIIIA (CD16) and by high levels of proinflammatory cytokine secretion and cytotoxic activity. Although donor-specific stimulation induced a similar rapid, early response in EM and TEMRA CD8+T cells, CD16 engagement resulted in selective activation of TEMRA CD8+T cells, which mediated antibody-dependent cytotoxicity. Conclusions: At 1 year post-transplant, the composition of memory CD8+T cell subsets in blood improved prediction of 8-year kidney transplant failure compared with a clinical-variables score alone. A subpopulation of TEMRA CD8+T cells displays a novel dual mechanism of activation mediated by engagement of the T-cell receptor or of CD16. These findings suggest that TEMRA CD8+T cells play a pivotal role in humoral and cellular rejection and reveal the potential value of memory CD8+T cell monitoring for predicting risk of kidney transplant failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mixOmics: An R package for ‘omics feature selection and multiple data integration
Rohart, F., Gautier, B., Singh, A., & Lê Cao, K.-A. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005752 · Cited by 4,056
Adaptive linear step-up procedures that control the false discovery rate
Benjamini, Y., Krieger, A. M., & Yekutieli, D. (2006) · Biometrika · doi:10.1093/biomet/93.3.491 · Cited by 3,228
Khan, N., Shariff, N., Cobbold, M., Bruton, R., Ainsworth, J. A., Sinclair, A. J., Nayak, L., & Moss, P. A. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1984 · Cited by 754
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
McKinney, E. F., Lee, J. C., Jayne, D. R. W., Lyons, P. A., & Smith, K. G. C. (2015) · Nature · doi:10.1038/nature14468 · Cited by 685
Reprogramming of T Cells to Natural Killer–Like Cells upon Bcl11b Deletion
Li, P., Burke, S., Wang, J., Chen, X., Ortiz, M., Lee, S.-C., Lu, D., Campos, L., Goulding, D., Ng, B. L., et al. (2010) · Science · doi:10.1126/science.1188063 · Cited by 374
Wertheimer, A. M., Bennett, M. S., Park, B., Uhrlaub, J. L., Martinez, C., Pulko, V., Currier, N. L., Nikolich-Žugich, D., Kaye, J., & Nikolich-Žugich, J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301721 · Cited by 352
Blanche, P., Dartigues, J., & Jacqmin‐Gadda, H. (2013) · Biometrical Journal · doi:10.1002/bimj.201200045 · Cited by 94
Cited by
Complement activation induces excessive T cell cytotoxicity in severe COVID-19
Georg, P., Astaburuaga-García, R., Bonaguro, L., Brumhard, S., Michalick, L., Lippert, L. J., Kostevc, T., Gäbel, C., Schneider, M., Streitz, M., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.040 · Cited by 218
“Box plots showing plasma expression levels erent between samples from severe COVID-19 patients (WHO 5–7) who were ilcoxon and post hoc Benjamini-Hochberg test). ll OPEN ACCESSArticle inflammation (Björkström et al., 2008; Clémenceau et al., 2011; Jacquemont et al., 2020).”
Allorecognition and the spectrum of kidney transplant rejection
Callemeyn, J., Lamarthée, B., Koenig, A., Koshy, P., Thaunat, O., & Naesens, M. (2022) · Kidney International · doi:10.1016/j.kint.2021.11.029 · Cited by 189
Age-Related Adaptive Immune Changes in Parkinson’s Disease
Kouli, A., & Williams-Gray, C. H. (2022) · Journal of Parkinson's Disease · doi:10.3233/jpd-223228 · Cited by 20
“CD8 TEMRAs remain highly cytotoxic on stimulation by their specific target antigen and they are known to contribute to certain disease states, for example they have been implicated in driving graft failure in renal transplant patients [82].”
Background
Metadata
- Authors
- Jacquemont, L., Tilly, G., Yap, M., Doan-Ngoc, T.-M., Danger, R., Guérif, P., Delbos, F., Martinet, B., Giral, M., Foucher, Y., Brouard, S., & Degauque, N.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2020-03-12
- Volume
- 31
- Issue
- 4
- Pages
- 876-891
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- OpenAlex
- W3011507190
- Cited by
- 78
- References
- 7
- FWCI
- 8.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure. https://app.cochat.ai/papers/10.1681/asn.2019080847
- The paper
- Jacquemont, L., Tilly, G., Yap, M., Doan-Ngoc, T.-M., Danger, R., Guérif, P., Delbos, F., Martinet, B., Giral, M., Foucher, Y., Brouard, S., & Degauque, N. (2020). Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2019080847
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.